Veracyte, Inc. (VCYT)
NASDAQ: VCYT · Real-Time Price · USD
23.64
+0.13 (0.55%)
At close: Aug 1, 2025, 4:00 PM
23.29
-0.35 (-1.48%)
After-hours: Aug 1, 2025, 7:53 PM EDT
Veracyte Market Cap
Veracyte has a market cap or net worth of $1.85 billion as of August 1, 2025. Its market cap has decreased by -5.25% in one year.
Market Cap
1.85B
Enterprise Value
1.61B
1-Year Change
-5.25%
Ranking
Category
Stock Price
$23.64
Market Cap Chart
Since October 30, 2013, Veracyte's market cap has increased from $274.10M to $1.85B, an increase of 575.43%. That is a compound annual growth rate of 17.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 1.84B | -40.01% |
| Dec 31, 2024 | 3.07B | 52.74% |
| Dec 29, 2023 | 2.01B | 18.01% |
| Dec 30, 2022 | 1.70B | -41.83% |
| Dec 31, 2021 | 2.93B | 3.30% |
| Dec 31, 2020 | 2.83B | 107.80% |
| Dec 31, 2019 | 1.36B | 167.37% |
| Dec 31, 2018 | 510.00M | 129.42% |
| Dec 29, 2017 | 222.30M | 2.77% |
| Dec 30, 2016 | 216.30M | 8.58% |
| Dec 31, 2015 | 199.20M | -8.37% |
| Dec 31, 2014 | 217.40M | -28.72% |
| Dec 31, 2013 | 305.00M | 11.27% |
| Oct 30, 2013 | 274.10M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 685.74B |
| Johnson & Johnson | 403.16B |
| AbbVie | 346.92B |
| AstraZeneca | 232.21B |
| Novartis AG | 224.47B |
| Abbott Laboratories | 221.54B |
| UnitedHealth Group | 215.45B |
| Novo Nordisk | 211.90B |